Chengdu Kanghua Biological Products Strategic Asset Allocation Index
Chengdu Kanghua Biological Products strategic asset allocation index. Chengdu Kanghua Biological Products (300841) has a Strategic Asset Allocation Index of 28.2% as of September 2023. Strategic assets (PP&E of CN¥954.01 Million plus long-term investments of CN¥-) total CN¥954.01 Million, measured against net assets of CN¥3.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Chengdu Kanghua Biological Products (300841) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Chengdu Kanghua Biological Products (2017–2022)
Strategic asset allocation index of Chengdu Kanghua Biological Products from 2017 to 2022. This chart shows how Chengdu Kanghua Biological Products's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of September 2023, the index stands at 28.2%, representing strategic assets of CN¥954.01 Million against net assets of CN¥3.38 Billion CNY. Check Chengdu Kanghua Biological Products tangible equity quality to evaluate the tangible quality of the company's equity base.
Chengdu Kanghua Biological Products Strategic Asset Allocation Index by Year (2017–2022)
Chengdu Kanghua Biological Products strategic asset allocation index by year from 2017 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Chengdu Kanghua Biological Products from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300841 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.0% | CN¥985.45 Million | CN¥985.45 Million | CN¥- | CN¥3.08 Billion | ▲ +13.7 pp |
| 2021 | 18.3% | CN¥488.72 Million | CN¥488.72 Million | CN¥- | CN¥2.67 Billion | ▲ +8.1 pp |
| 2020 | 10.2% | CN¥202.13 Million | CN¥202.13 Million | CN¥- | CN¥1.97 Billion | ▼ -3.7 pp |
| 2019 | 13.9% | CN¥79.85 Million | CN¥79.85 Million | CN¥- | CN¥574.65 Million | ▼ -8.2 pp |
| 2018 | 22.1% | CN¥81.11 Million | CN¥81.11 Million | CN¥- | CN¥367.70 Million | ▼ -4.9 pp |
| 2017 | 27.0% | CN¥50.82 Million | CN¥50.82 Million | CN¥- | CN¥188.37 Million | — |